Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Aptevo Therapeutics Inc’s current trading price is -99.21% away from its 52-week high, while its distance from the 52-week low is 79.67%. The stock’s price range over this period has fluctuated between $0.28 and $64.90. The company, operating within the financial sector, had a trading volume of approximately 234.26 million for the day, which was noticeably higher than the average daily share volume of 0.99 million over the last 3 months.
Aptevo Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $64.90 on 07/18/23 and a low of $0.28 for the same time frame on 07/05/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Aptevo Therapeutics Inc (APVO) has experienced a quarterly decline of -33.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.94M and boasts a workforce of 40 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0986, with a change in price of -5.5818. Similarly, Aptevo Therapeutics Inc recorded 3,007,077 in trading volume during the last 100 days, posting a change of -91.27%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for APVO stands at 0.85. Similarly, the long-term debt-to-equity ratio is also 0.85.
APVO Stock Stochastic Average
Today’s raw stochastic average for Aptevo Therapeutics Inc over the last 50 days is 27.55%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 67.37%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 27.96% and 13.69%, respectively.
APVO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -93.57% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -92.01%. Over the past 30 days, the price of APVO has leaped by -33.35%. And in the last five days, it has surged by 73.40%.
